Nexesa Injection 200
Marketer
Lupin Ltd
Salt Composition
Darbepoetin alfa (200mcg)
Overview Nexesa Injection 200
Epoetin alfa injection (200 units) treats anemia stemming from chronic kidney disease or chemotherapy. Its mechanism involves bone marrow stimulation for increased red blood cell production. Administered under strict medical supervision, this medication demands careful use due to potential serious adverse reactions. Expert medical guidance is crucial; patients must adhere precisely to their physician's instructions. Common side effects encompass abdominal discomfort, hypertension, skin rash, injection site pain, dyspnea, cough, and peripheral edema. Report severe headaches, visual disturbances, nausea, vomiting, or seizures (indicative of dangerously high blood pressure) immediately. Regular blood tests monitoring electrolytes (like potassium), hemoglobin, and blood cell counts are typically ordered. Discontinue use and seek medical attention if shortness of breath or a skin rash develops. Prior to commencing treatment, disclose any history of heart disease, hypertension, seizures, or strokes. Pregnant, breastfeeding, or planning pregnancy/breastfeeding women should consult their doctor regarding safety.
Uses of Nexesa Injection 200
Managing anemia in chronic kidney disease patients | Addressing chemotherapy-induced anemia
Major Benefits of Nexesa Injection 200:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Nexesa Injection 200:
- Abdominal pain
- High blood pressure
- Rash
- Injection site pain
- Breathlessness
- Cough
- Peripheral edema
- Procedural hypotension (low blood pressure)
- Convulsion
- Thromboembolism
How to use Nexesa Injection 200:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Nexesa Injection 200 works:
Darbepoetin alfa injection (200 mcg) boosts red blood cell production. This medication, an erythropoiesis stimulator, acts by prompting the bone marrow — the blood cell-forming tissue within bones — to increase red blood cell generation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Nexesa Injection 200 may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Nexesa Injection 200 during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Physician consultation is recommended.
Breast feedingCONSULT YOUR DOCTOR
Administration of Nexesa Injection 200 while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Nexesa Injection 200.
KidneySAFE IF PRESCRIBED
Nexesa Injection 200 poses no safety concerns for patients with renal impairment; no dosage modification is necessary.
LiverCAUTION
Patients with hepatic impairment should use Nexesa Injection 200 judiciously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Nexesa Injection 200 :
Should you forget a dose of Nexesa Injection 200, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Nexesa Injection 200
| Label | Value |
|---|---|
| Chemical Category | Amino Acid and Peptide Analogs |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | Erythropoietin-stimulating drug |
3,018 People bought this recently